Search Orphan Drug Designations and Approvals
-
| Generic Name: | recombinant human thrombopoietin (rhTPO) |
|---|---|
| Date Designated: | 07/31/2024 |
| Orphan Designation: | treatment of primary immune thrombocytopenia (ITP) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
3SBIO Inc. (Shenyang Sunshine Pharmaceuticals CO., Ltd.) 1st 3, 10th Road, Economic and Technological Development Zone Shenyang China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







